Close

Published Real World Evidence Demonstrates KidneyIntelX™ Improved Clinical Decisions and Outcomes in High-Risk Patients with Early-Stage Diabetic Kidney Disease Nov 29, 2022 07:00AM
Singing River Health System and Renalytix Join Forces to Improve Kidney Health on the Mississippi Gulf Coast Jan 10, 2022 07:00AM
American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population Jan 4, 2022 07:00AM
Mount Sinai Initiates System-wide Scale-Up of Renalytix KidneyIntelX™ Enabled Health Care Model Sep 14, 2021 07:00AM
Kantaro's Semi-Quantitative Antibody Test Kit Receives Health Canada Authorization Under the COVID-19 Interim Order Jun 2, 2021 11:34AM


May 4, 2021 02:20PM Kantaro's COVID-SeroKlir Antibody Test Named As A Finalist For Fast Company's 2021 World Changing Ideas Awards
Mar 10, 2021 10:31AM Kantaro Biosciences Named to Fast Company's Annual List of the World's Most Innovative Companies for 2021 and Ranked First in the Joint Ventures Category
Feb 10, 2021 11:33AM FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma (RNLX)
Feb 10, 2021 11:31AM FDA Adds Kantaro's Semi-Quantitative COVID-19 Antibody Test to Revised Emergency Use Authorization for Convalescent Plasma
Feb 8, 2021 07:30AM Kantaro and Atrys Health Partnership Expand Global Footprint of Quantitative COVID-19 Antibody Tests in Europe and South America
Dec 2, 2020 08:04AM NKF and RenalytixAI Partner to Improve Management of Early Stage Kidney Disease
Nov 25, 2020 07:31AM Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies (RNLX)
Nov 25, 2020 07:30AM Kantaro Receives FDA Emergency Use Authorization for Semi-Quantitative COVID-19 Antibody Test Kit that Detects the Presence and Level of SARS-CoV-2 IgG Antibodies
Oct 28, 2020 07:30AM EKF and Kantaro Partner to Market Quantitative COVID-19 Antibody Testing in the UK and Europe
Oct 26, 2020 07:35AM CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex Quantitative Antibody Test Kits (RENX) (TECH)
Oct 26, 2020 07:30AM CE Mark Approval Granted to Kantaro COVID-SeroKlir and COVID-SeroIndex Quantitative Antibody Test Kits
Sep 18, 2020 07:00AM RenalytixAI Reaches Milestone of KidneyIntelX Commercial Testing with Mount Sinai Health System
Aug 3, 2020 08:00AM KidneyIntelX in Multi-Center Study to Monitor and Predict Kidney Risk in COVID-19 Patients
May 19, 2020 04:06PM Bio-Techne (TECH), Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test
May 19, 2020 04:05PM Bio-Techne And Kantaro Biosciences Announce Partnership To Develop And Scale Production Of COVID-19 Serology Test
Oct 17, 2019 07:00AM RenalytixAI Partners with Capital District Physicians' Health Plan, Inc. on KidneyIntelX™
Mar 27, 2018 11:04AM Omnicom Health Group acquires Elsevier's Pharma Communications business in Japan, rebrands as EMC K.K.